v3.25.1
Consolidated Statements of Changes in Stockholders' (Deficit) Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2022 $ 8,000 $ 508,584,000 $ (501,613,000) $ 6,979,000
Balance, shares at Dec. 31, 2022 8,306,326      
Net loss (16,690,000) (16,690,000)
Common stock issued under 2024 At the Market Agreement, net of issuance costs of $189 68,000 68,000
Common stock issued under 2024 At the Market Agreement, net of issuance costs, shares 35,552      
Common stock issued under 2023 Equity Line of Credit Agreement 1,177,000 1,177,000
Common stock issued under Equity Line of Credit Agreement, shares 360,943      
Common stock issued for entering into 2023 Equity Line of Credit Agreement 258,000 258,000
Common stock issued for entering into Equity Line of Credit Agreement, shares 47,733      
Common stock issued under 2024 Direct Offering, net of issuance costs of $733 $ 2,000 4,117,000 4,119,000
Common stock issued under Direct Offering, net of issuance costs, shares 1,694,820      
Common stock issued for vested restricted stock awards $ 1,000 814,000 815,000
Common stock issued for vested restricted stock awards, shares 199,699      
Stock-based compensation expense 909,000 909,000
Fractional shares adjustment related to reverse stock split
Fractional shares adjustment related to reverse stock split, shares (24)      
Balance at Dec. 31, 2023 $ 11,000 515,927,000 (518,303,000) (2,365,000)
Balance, shares at Dec. 31, 2023 10,645,049      
Net loss (13,094,000) (13,094,000)
Common stock issued under 2024 At the Market Agreement, net of issuance costs of $189 $ 1,000 714,000 715,000
Common stock issued under 2024 At the Market Agreement, net of issuance costs, shares 1,073,050      
Common stock issued under 2023 Equity Line of Credit Agreement $ 1,000 1,900,000 1,901,000
Common stock issued under Equity Line of Credit Agreement, shares 949,574      
Common stock issued under 2024 Direct Offering, net of issuance costs of $733 $ 1,000 4,829,000 4,830,000
Common stock issued under Direct Offering, net of issuance costs, shares 1,371,000      
Common stock issued for vested restricted stock awards 161,000 161,000
Common stock issued for vested restricted stock awards, shares 199,076      
Stock-based compensation expense 1,333,000 1,333,000
Common stock issued under Warrant Inducement Agreement, net of issuance costs of $277 $ 2,000 1,860,000 1,862,000
Common stock issued under Warrant Inducement Agreement, net of issuance costs, shares 1,711,111      
Reclassification of Warrant Liability upon Exercise 245,000 245,000
Common stock issued under 2024 Private Placement Offering, net of issuance costs of $72 $ 1,000 1,837,000 1,838,000
Common stock issued under Private Placement Offering, net of issuance costs, shares 1,248,527      
Common stock issued under 2024 Securities Purchase Agreements 11,000 11,000
Common stock issued under Securities Purchase Agreements, shares 9,733      
Warrant Exercise
Warrant Exercise, shares 200,000      
Balance at Dec. 31, 2024 $ 17,000 $ 528,817,000 $ (531,397,000) $ (2,563,000)
Balance, shares at Dec. 31, 2024 17,407,120